Chemours: A Cyclical Dip & Refrigerant Dreams

The earnings report, shall we say, lacked the effervescence of a well-shaken cocktail. Guidance met expectations, which, in the world of high finance, is akin to receiving a slightly used postage stamp. The stock, having doubled since late November – a feat worthy of a carnival magician – found itself decidedly downcast. Still, one suspects opportunity lurks within, like a hidden compartment in a bureau.








